Optimum Perspectives
By Optimum Strategic Communications
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Optimum Strategic Communications
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 39
Description
Follow us on Linkedin and Twitter for news and highlights on the life sciences industry. Reach out via our contact page on our website: www.optimumcomms.com
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
How sleep architecture shapes brain health: new frontiers in Alzheimer’s research
|
Mar 13, 2026 |
|
Closing the gap on rare diseases in 2026
|
Feb 26, 2026 |
|
Why who funds science matters
|
Feb 11, 2026 |
|
Tackling the threat of AMR
|
Nov 13, 2025 |
|
The ups and downs of ADCs – where to now?
|
Nov 03, 2025 |
|
Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease
|
Aug 05, 2025 |
|
Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025
|
Jun 25, 2025 |
|
Stronger together: changing the future of muscle wasting condition
|
Feb 28, 2025 |
|
How bioengineered spider silk-based proteins are changing the world
|
Feb 06, 2025 |
|
How to have a perfect IPO on NASDAQ
|
Jan 23, 2025 |
|
Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers
|
Nov 27, 2024 |
|
Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer
|
Nov 21, 2024 |
|
DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology
|
Nov 05, 2024 |
|
SpliceBio: Celebrating progress in ophthalmology research on World Sight Day
|
Oct 10, 2024 |
|
Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine
|
Sep 12, 2024 |
|
Resolution Therapeutics: pioneering macrophage therapies for liver diseases
|
Aug 08, 2024 |
|
Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader
|
Jul 25, 2024 |
|
How AI is revolutionising drug research
|
May 30, 2024 |
|
Curve Therapeutics – Addressing challenging drug targets
|
May 23, 2024 |
|
Biotech IPOs make a comeback in 2024
|
May 16, 2024 |
|
Anglonordic Life Science Conference strikes optimistic note for ‘24
|
May 07, 2024 |
|
The challenges of recruitment for clinical trials
|
Apr 04, 2024 |
|
Lytix Biopharma – Innovations in Killing Cancer
|
Mar 07, 2024 |
|
Tackling Rare Diseases in 2024
|
Feb 29, 2024 |
|
International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman
|
Feb 08, 2024 |
|
Optimum's European Life Sciences Investor Survey 2024
|
Jan 23, 2024 |
|
Vicore Pharma: Restoring lung function for IPF patients
|
Dec 12, 2023 |
|
Optimum's Christmas charity special featuring Ariana Smiles
|
Dec 06, 2023 |
|
4SC: Creating a new treatment paradigm for CTCL
|
Nov 21, 2023 |
|
Episode 10: Optimum's 15th Annual Healthcare Investor Conference Special
|
Nov 02, 2023 |
|
Ask Eva: biopharma's market trends in 2023
|
Sep 07, 2023 |
|
Alchemab: The UK biotech that is revolutionising drug discovery
|
Aug 22, 2023 |
|
Poolbeg Pharma: Using AI to prepare for the next pandemic
|
Aug 08, 2023 |
|
Verona Pharma: Preparing a potentially novel COPD medicine for market
|
Jul 24, 2023 |
|
Søren Møller of Novo Holdings Seed Investments – Helping small biotechs weather the storm
|
Jun 26, 2023 |
|
Renée Aguiar-Lucander, CEO of Calliditas Therapeutics: Blazing a trail in rare diseases
|
Jun 13, 2023 |
|
An interview with Dan Mahony, UK Government Life Sciences Envoy, by Optimum’s Eva Haas
|
Apr 27, 2023 |
|
Versameb: Revolutionizing SUI therapy with mRNA technology
|
Apr 19, 2023 |
|
CellCentric's new oral cancer therapy inobrodib
|
Jan 23, 2023 |